SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001214659-20-003985
Filing Date
2020-05-04
Accepted
2020-05-04 08:19:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 m53201sc13d.htm SC 13D 46927
  Complete submission text file 0001214659-20-003985.txt   48157
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Subject) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90395 | Film No.: 20842850
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 11 SUMMIT LANE GREENVILLE DE 19807
Business Address
Grant Stuart M. (Filed by) CIK: 0001783415 (see all company filings)

Type: SC 13D